Optimization of autologous muscle stem cell survival in the denervated hemilarynx

Laryngoscope

Volumn 118, Issue 7, 2008, Pages 1308-1312

  Halum, Stacey L ^a   Hiatt, Kelly K ^a   Naidu, Moumita ^a   Sufyan, Ahmed S ^a   Clapp, D Wade ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Atrophy; Ciliary derived neurotrophic factor; CNTF; IGF 1; Insulin like growth factor 1; Laryngeal denervation; Laryngeal paralysis; Muscle stem cells; Myoblasts; Myofiber; Neurotrophic factors; Satellite cell; Vocal cord paralysis; Vocal fold paralysis

Indexed keywords

CARDIOTOXIN; CILIARY NEUROTROPHIC FACTOR; ENHANCED GREEN FLUORESCENT PROTEIN; PLACEBO; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; LARYNX; MALE; MUSCLE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DENERVATION; NERVE INJURY; NERVE REGENERATION; NERVE TRANSECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT LARYNGEAL NERVE; RECURRENT LARYNGEAL NERVE PALSY; STEM CELL; THYROARYTENOID MUSCLE; ANIMAL; AUTOTRANSPLANTATION; BIOPSY; CYTOLOGY; FLUORESCENCE MICROSCOPY; INJURY; LARYNX MUSCLE; MYOBLAST; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; VOCAL CORD PARALYSIS; WISTAR RAT;

ANIMALS; BIOPSY; CELL SURVIVAL; LARYNGEAL MUSCLES; MICROSCOPY, FLUORESCENCE; MUSCLE DENERVATION; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOBLASTS; NERVE REGENERATION; RATS; RATS, WISTAR; RECURRENT LARYNGEAL NERVE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; VOCAL CORD PARALYSIS;

EID: 47149114928     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31816c438e     Document Type: Article

References (19)

1. Halum SL, Naidu M, Delo DM, Atala A, Hingtgen CM. Injection of autologous muscle stem cells (MSCs) for the treatment of vocal fold paralysis: a pilot study. Laryngoscope 2007;117:917-922.
2. Caroni P, Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J Cell Biol 1990;110: 1307-1317.
3. Day CS, Buranapanitkit B, Riano FA, et al. Insulin growth factor-1 decreases muscle atrophy following denervation. Microsurgery 2002;22:144-151.
4. Rabinovsky ED, Draghia-Akli R. Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis. Mol Ther 2004;9:46-55.
5. Newman JP, Verity AN, Hawatmeh S, Fee WE Jr, Terris DJ. Ciliary-derived neurotrophic factor (CNTF) enhances peripheral nerve regeneration. Arch Otolaryngol Head Neck Surg 1996;122:399-403.
6. Kwon YW, Gurney ME. Systemic injections of ciliary neurotrophic factor induce sprouting by adult motor neurons. Neuroreport 1994;21:5:789-792.
7. Helgren ME, Squinto SP, Davis HL, et al. Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell 1994;76:493-504.
8. Lazerges C, Daussin PA, Coulet B, et al. Transplantation of primary satellite cells improves properties of reinnervated skeletal muscles. Muscle Nerve 2004;29:218-226.
9. Nakagawa H, Shiotani A, O'Malley BW, Coleman ME, Flint PW. Timing of human insulin-like growth factor-1 gene transfer in re innervating laryngeal muscle. Laryngoscope 2004;114:726-732.
10. Shiotani A, O'Malley BW Jr, Coleman ME, Alila HW, Flint PW. Re innervation of motor endplates and increased muscle fiber size after human insulin-like growth factor I gene transfer into the paralyzed larynx. Hum Gene Ther 1998;9:2039-2047.
11. Flint PW, Shiotani A, O'Malley BW Jr. IGF-1 gene transfer into denervated rat laryngeal muscle. Arch Otolaryngol Head Neck Surg 1999;125:274-279.
12. Shiotani A, O'Malley BW Jr, Coleman ME, Flint PW. Human insulinlike growth factor 1 gene transfer into paralyzed rat larynx: single vs. multiple injection. Arch Otolaryngol Head Neck Surg 1999;125:555-560.
13. Li S, Kimura E, Fall BM. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Ther 2005;12:1099-1108.
14. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002;346: 1185-1193.
15. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-256.
16. Richler C, Yaffe D. The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev Biol 1970;23:1-22.
17. Chachques JC, Herreros J, Trainini J, et al. Autologous human serum for cell culture avoids implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004;95 (Supp. 1) :S29-S33.
18. Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscl e-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003;24:2012-2020.
19. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41: 879-888.